The Philippine journal of science.

v.21 (1922)

La asimilación del paradigma moderno de la ciencia en Córdoba. La Physica Particularis de Elías del Carmen Pereyra (1786). Transcripción, versión española y estudio. The assumption of the Modern Paradigm of Science in Córdoba. Physica Particularis by Elías del Carmen Pereira (1786). Transcription, spanish version and study.

El presente trabajo aborda el estudio multidisciplinario de las ideas acerca de la física y la ciencia en general en Córdoba en el siglo XVIII a través de Physica Particularis de Elías del Carmen Pereira (1786), texto manuscrito en lengua latina inédito y recuperado luego de dos siglos de desaparición. El trabajo comprende su transcripción paleográfica, versión española y estudio centrado en la asimilación del paradigma de la ciencia moderna y su enseñanza en la universidad. Se atenderá especialmente a los conceptos que permiten ver en este texto un grado notable de actualización y conocimiento de las ideas de científicos contemporáneos como Nollet y Newton.

Proceedings of the Committee of Science and Correspondence of the Zoological Society of London.

pt.1-2 (1830-1832)

Annual record of science and industry.

1872

Annual record of science and industry.

1878

Annual record of science and industry.

1877

Annual record of science and industry.

1874

Annual record of science and industry.

1871

Long-term Outcomes of Drug-eluting versus Bare-metal stent for ST-elevation Myocardial Infarction

Background:Long-term outcomes of drug-eluting stents (DES) versus bare-metal stents (BMS) in patients with ST-segment elevation myocardial infarction (STEMI) remain uncertain.Objective:To investigate long-term outcomes of drug-eluting stents (DES) versus bare-metal stents (BMS) in patients with ST-segment elevation myocardial infarction (STEMI).Methods:We performed search of MEDLINE, EMBASE, the Cochrane library, and ISI Web of Science (until February 2013) for randomized trials comparing more than 12-month efficacy or safety of DES with BMS in patients with STEMI. Pooled estimate was presented with risk ratio (RR) and its 95% confidence interval (CI) using random-effects model.Results:Ten trials with 7,592 participants with STEMI were included. The overall results showed that there was no significant difference in the incidence of all-cause death and definite/probable stent thrombosis between DES and BMS at long-term follow-up. Patients receiving DES implantation appeared to have a lower 1-year incidence of recurrent myocardial infarction than those receiving BMS (RR = 0.75, 95% CI 0.56 to 1.00, p= 0.05). Moreover, the risk of target vessel revascularization (TVR) after receiving DES was consistently lowered during long-term observation (all p< 0.01). In subgroup analysis, the use of everolimus-eluting stents (EES) was associated with reduced risk of stent thrombosis in STEMI patients (RR = 0.37, p=0.02).Conclusions:DES did not increase the risk of stent thrombosis in patients with STEMI compared with BMS. Moreover, the use of DES did lower long-term risk of repeat revascularization and might decrease the occurrence of reinfarction.

Annual record of science and industry.

1876

Annual record of science and industry.

1875